China Pain Management Drugs Market Report & Forecast 2021-2027

Publisher Name :
Date: 27-Aug-2021
No. of pages: 109
Inquire Before Buying

This report contains market size and forecasts of Pain Management Drugs in China, including the following market information:

China Pain Management Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

China top five Pain Management Drugs companies in 2020 (%)

The global Pain Management Drugs market size is expected to growth from US$ 34960 million in 2020 to US$ 37310 million by 2027; it is expected to grow at a CAGR of 0.9% during 2021-2027.

The China Pain Management Drugs market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Pain Management Drugs Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Pain Management Drugs Market, By Type, 2016-2021, 2022-2027 ($ Millions)

China Pain Management Drugs Market Segment Percentages, By Type, 2020 (%)

- Generic Opioids

- Branded Opioids

- NSAIDs

- Others

China Pain Management Drugs Market, By Application, 2016-2021, 2022-2027 ($ Millions)

China Pain Management Drugs Market Segment Percentages, By Application, 2020 (%)

- Hospitals

- Drugstores

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Pain Management Drugs revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Pain Management Drugs revenues share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- GSK

- Pfizer

- Grunenthal

- Sanofi

- Bayer

- AstraZeneca

- Eli Lilly

- Endo

- Merck

- Yunnan Baiyao

- Teikoku Seiyaku

- Teva

- J&J

- Assertio Therapeutics

- Allergan

China Pain Management Drugs Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Pain Management Drugs Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Pain Management Drugs Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Pain Management Drugs Overall Market Size
2.1 China Pain Management Drugs Market Size: 2021 VS 2027
2.2 China Pain Management Drugs Revenue, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pain Management Drugs Players in China Market
3.2 Top China Pain Management Drugs Companies Ranked by Revenue
3.3 China Pain Management Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pain Management Drugs Companies in China Market, by Revenue in 2020
3.5 Companies Pain Management Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pain Management Drugs Players in China Market
3.6.1 List of Tier 1 Pain Management Drugs Companies in China
3.6.2 List of Tier 2 and Tier 3 Pain Management Drugs Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Pain Management Drugs Market Size Markets, 2021 & 2027
4.1.2 Generic Opioids
4.1.3 Branded Opioids
4.1.4 NSAIDs
4.1.5 Others
4.2 By Type - China Pain Management Drugs Revenue & Forecasts
4.2.1 By Type - China Pain Management Drugs Revenue, 2016-2021
4.2.2 By Type - China Pain Management Drugs Revenue, 2022-2027
4.2.3 By Type - China Pain Management Drugs Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Pain Management Drugs Market Size, 2021 & 2027
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - China Pain Management Drugs Revenue & Forecasts
5.2.1 By Application - China Pain Management Drugs Revenue, 2016-2021
5.2.2 By Application - China Pain Management Drugs Revenue, 2022-2027
5.2.3 By Application - China Pain Management Drugs Revenue Market Share, 2016-2027
6 Pain Management Drugs Companies Profiles
6.1 GSK
6.1.1 GSK Company Details
6.1.2 GSK Business Overview
6.1.3 GSK Pain Management Drugs Introduction
6.1.4 GSK Pain Management Drugs Revenue in China Market (2016-2021)
6.1.5 GSK Recent Developments
6.2 Pfizer
6.2.1 Pfizer Company Details
6.2.2 Pfizer Business Overview
6.2.3 Pfizer Pain Management Drugs Introduction
6.2.4 Pfizer Pain Management Drugs Revenue in China Market (2016-2021)
6.2.5 Pfizer Recent Developments
6.3 Grunenthal
6.3.1 Grunenthal Company Details
6.3.2 Grunenthal Business Overview
6.3.3 Grunenthal Pain Management Drugs Introduction
6.3.4 Grunenthal Pain Management Drugs Revenue in China Market (2016-2021)
6.3.5 Grunenthal Recent Developments
6.4 Sanofi
6.4.1 Sanofi Company Details
6.4.2 Sanofi Business Overview
6.4.3 Sanofi Pain Management Drugs Introduction
6.4.4 Sanofi Pain Management Drugs Revenue in China Market (2016-2021)
6.4.5 Sanofi Recent Developments
6.5 Bayer
6.5.1 Bayer Company Details
6.5.2 Bayer Business Overview
6.5.3 Bayer Pain Management Drugs Introduction
6.5.4 Bayer Pain Management Drugs Revenue in China Market (2016-2021)
6.5.5 Bayer Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Company Details
6.6.2 AstraZeneca Business Overview
6.6.3 AstraZeneca Pain Management Drugs Introduction
6.6.4 AstraZeneca Pain Management Drugs Revenue in China Market (2016-2021)
6.6.5 AstraZeneca Recent Developments
6.7 Eli Lilly
6.7.1 Eli Lilly Company Details
6.7.2 Eli Lilly Business Overview
6.7.3 Eli Lilly Pain Management Drugs Introduction
6.7.4 Eli Lilly Pain Management Drugs Revenue in China Market (2016-2021)
6.7.5 Eli Lilly Recent Developments
6.8 Endo
6.8.1 Endo Company Details
6.8.2 Endo Business Overview
6.8.3 Endo Pain Management Drugs Introduction
6.8.4 Endo Pain Management Drugs Revenue in China Market (2016-2021)
6.8.5 Endo Recent Developments
6.9 Merck
6.9.1 Merck Company Details
6.9.2 Merck Business Overview
6.9.3 Merck Pain Management Drugs Introduction
6.9.4 Merck Pain Management Drugs Revenue in China Market (2016-2021)
6.9.5 Merck Recent Developments
6.10 Yunnan Baiyao
6.10.1 Yunnan Baiyao Company Details
6.10.2 Yunnan Baiyao Business Overview
6.10.3 Yunnan Baiyao Pain Management Drugs Introduction
6.10.4 Yunnan Baiyao Pain Management Drugs Revenue in China Market (2016-2021)
6.10.5 Yunnan Baiyao Recent Developments
6.11 Teikoku Seiyaku
6.11.1 Teikoku Seiyaku Company Details
6.11.2 Teikoku Seiyaku Business Overview
6.11.3 Teikoku Seiyaku Pain Management Drugs Introduction
6.11.4 Teikoku Seiyaku Pain Management Drugs Revenue in China Market (2016-2021)
6.11.5 Teikoku Seiyaku Recent Developments
6.12 Teva
6.12.1 Teva Company Details
6.12.2 Teva Business Overview
6.12.3 Teva Pain Management Drugs Introduction
6.12.4 Teva Pain Management Drugs Revenue in China Market (2016-2021)
6.12.5 Teva Recent Developments
6.13 J&J
6.13.1 J&J Company Details
6.13.2 J&J Business Overview
6.13.3 J&J Pain Management Drugs Introduction
6.13.4 J&J Pain Management Drugs Revenue in China Market (2016-2021)
6.13.5 J&J Recent Developments
6.14 Assertio Therapeutics
6.14.1 Assertio Therapeutics Company Details
6.14.2 Assertio Therapeutics Business Overview
6.14.3 Assertio Therapeutics Pain Management Drugs Introduction
6.14.4 Assertio Therapeutics Pain Management Drugs Revenue in China Market (2016-2021)
6.14.5 Assertio Therapeutics Recent Developments
6.15 Allergan
6.15.1 Allergan Company Details
6.15.2 Allergan Business Overview
6.15.3 Allergan Pain Management Drugs Introduction
6.15.4 Allergan Pain Management Drugs Revenue in China Market (2016-2021)
6.15.5 Allergan Recent Developments
7 Conclusion
8 Appendix
8.1 Note
8.2 Examples of Clients
8.3 Author Details
8.4 Disclaimer
List of Tables
Table 1. Pain Management Drugs Market Opportunities & Trends in China Market
Table 2. Pain Management Drugs Market Drivers in China Market
Table 3. Pain Management Drugs Market Restraints in China Market
Table 4. Key Players of Pain Management Drugs in China Market
Table 5. Top Pain Management Drugs Players in China Market, Ranking by Revenue (2019)
Table 6. China Pain Management Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. China Pain Management Drugs Revenue Share by Companies, 2016-2021
Table 8. Companies Pain Management Drugs Product Type
Table 9. List of Tier 1 Pain Management Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Pain Management Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - China Pain Management Drugs Revenue, (US$, Mn), 2021 & 2027
Table 12. By Type - China Pain Management Drugs Revenue (US$, Mn), 2016-2021
Table 13. By Type - China Pain Management Drugs Revenue (US$, Mn), 2022-2027
Table 14. By Application - China Pain Management Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - China Pain Management Drugs Revenue (US$, Mn), 2016-2021
Table 16. By Application - China Pain Management Drugs Revenue (US$, Mn), 2022-2027
Table 17. GSK Company Details
Table 18. GSK Business Overview
Table 19. GSK Pain Management Drugs Product
Table 20. GSK Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 21. GSK Recent Developments
Table 22. Pfizer Company Details
Table 23. Pfizer Business Overview
Table 24. Pfizer Pain Management Drugs Product
Table 25. Pfizer Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 26. Pfizer Recent Developments
Table 27. Grunenthal Company Details
Table 28. Grunenthal Business Overview
Table 29. Grunenthal Pain Management Drugs Product
Table 30. Grunenthal Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 31. Grunenthal Recent Developments
Table 32. Sanofi Company Details
Table 33. Sanofi Business Overview
Table 34. Sanofi Pain Management Drugs Product
Table 35. Sanofi Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 36. Sanofi Recent Developments
Table 37. Bayer Company Details
Table 38. Bayer Business Overview
Table 39. Bayer Pain Management Drugs Product
Table 40. Bayer Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 41. Bayer Recent Developments
Table 42. AstraZeneca Company Details
Table 43. AstraZeneca Business Overview
Table 44. AstraZeneca Pain Management Drugs Product
Table 45. AstraZeneca Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 46. AstraZeneca Recent Developments
Table 47. Eli Lilly Company Details
Table 48. Eli Lilly Business Overview
Table 49. Eli Lilly Pain Management Drugs Product
Table 50. Eli Lilly Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 51. Eli Lilly Recent Developments
Table 52. Endo Company Details
Table 53. Endo Business Overview
Table 54. Endo Pain Management Drugs Product
Table 55. Endo Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 56. Endo Recent Developments
Table 57. Merck Company Details
Table 58. Merck Business Overview
Table 59. Merck Pain Management Drugs Product
Table 60. Merck Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 61. Merck Recent Developments
Table 62. Yunnan Baiyao Company Details
Table 63. Yunnan Baiyao Business Overview
Table 64. Yunnan Baiyao Pain Management Drugs Product
Table 65. Yunnan Baiyao Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 66. Yunnan Baiyao Recent Developments
Table 67. Teikoku Seiyaku Company Details
Table 68. Teikoku Seiyaku Business Overview
Table 69. Teikoku Seiyaku Pain Management Drugs Product
Table 70. Teikoku Seiyaku Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 71. Teikoku Seiyaku Recent Developments
Table 72. Teva Company Details
Table 73. Teva Business Overview
Table 74. Teva Pain Management Drugs Product
Table 75. Teva Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 76. Teva Recent Developments
Table 77. J&J Company Details
Table 78. J&J Business Overview
Table 79. J&J Pain Management Drugs Product
Table 80. J&J Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 81. J&J Recent Developments
Table 82. Assertio Therapeutics Company Details
Table 83. Assertio Therapeutics Business Overview
Table 84. Assertio Therapeutics Pain Management Drugs Product
Table 85. Assertio Therapeutics Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 86. Assertio Therapeutics Recent Developments
Table 87. Allergan Business Overview
Table 88. Allergan Company Details
Table 89. Allergan Pain Management Drugs Product
Table 90. Allergan Pain Management Drugs Revenue in China Market (2016-2021) & (US$ Million)
Table 91. Allergan Recent Developments
List of Figures
Figure 1. Pain Management Drugs Segment by Type
Figure 2. Pain Management Drugs Segment by Application
Figure 3. China Pain Management Drugs Market Overview: 2020
Figure 4. China Pain Management Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 5. China Pain Management Drugs Revenue, 2016-2027 (US$, Mn)
Figure 6. The Top 3 and 5 Players Market Share by Pain Management Drugs Revenue in 2020
Figure 7. By Type - China Pain Management Drugs Revenue Market Share, 2016-2027
Figure 8. By Application - China Pain Management Drugs Revenue Market Share, 2016-2027
Figure 9. GSK Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 10. Pfizer Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 11. Grunenthal Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 12. Sanofi Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 13. Bayer Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 14. AstraZeneca Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 15. Eli Lilly Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 16. Endo Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 17. Merck Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 18. Yunnan Baiyao Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 19. Teikoku Seiyaku Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. Teva Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. J&J Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Assertio Therapeutics Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Allergan Pain Management Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs